Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
The Journal of Urology
|
November 13, 2004
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?
Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Cancer Letters
|
March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer
Klaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Oncology Reports
|
January 14, 2004
Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome
Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Cancers
|
October 3, 2019
Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy
Antonia Franz, Bernhard Ralla, Sabine Weickmann, et al.
Cancers
|
September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
Bernhard Ralla, Jonas Busch, Anne Flörcken, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 17, 2015
Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients
Hongbiao Lu, Jonas Busch, Monika Jung, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 24, 2008
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse
Anja Rabien, Florian Fritzsche, Monika Jung, et al.
International Journal of Cancer
|
May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy
Anja Rabien, Florian R Fritzsche, Monika Jung, et al.
BMC Cancer
|
June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
Florian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
International Journal of Cancer
|
August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
Annika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
The Journal of Urology
|
November 13, 2004
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?
Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Cancer Letters
|
March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer
Klaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Oncology Reports
|
January 14, 2004
Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome
Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Cancers
|
October 3, 2019
Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy
Antonia Franz, Bernhard Ralla, Sabine Weickmann, et al.
Cancers
|
September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
Bernhard Ralla, Jonas Busch, Anne Flörcken, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 17, 2015
Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients
Hongbiao Lu, Jonas Busch, Monika Jung, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 24, 2008
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse
Anja Rabien, Florian Fritzsche, Monika Jung, et al.
International Journal of Cancer
|
May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy
Anja Rabien, Florian R Fritzsche, Monika Jung, et al.
BMC Cancer
|
June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
Florian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
International Journal of Cancer
|
August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
Annika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
Page
of 5